Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Cancer risks from arsenic in drinking water.

Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smith MT.

Environ Health Perspect. 1992 Jul;97:259-67. Review.

2.
3.
4.

Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan.

Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, Chen CJ.

Am J Epidemiol. 2001 Mar 1;153(5):411-8.

PMID:
11226969
5.

Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water.

Smith AH, Goycolea M, Haque R, Biggs ML.

Am J Epidemiol. 1998 Apr 1;147(7):660-9.

PMID:
9554605
6.

Cancer burden from arsenic in drinking water in Bangladesh.

Chen Y, Ahsan H.

Am J Public Health. 2004 May;94(5):741-4.

7.

Risk of internal cancers from arsenic in drinking water.

Morales KH, Ryan L, Kuo TL, Wu MM, Chen CJ.

Environ Health Perspect. 2000 Jul;108(7):655-61.

8.

Carcinogenic risks of inorganic arsenic in perspective.

Byrd DM, Roegner ML, Griffiths JC, Lamm SH, Grumski KS, Wilson R, Lai S.

Int Arch Occup Environ Health. 1996;68(6):484-94.

PMID:
8891790
9.

Arsenic, drinking water, and health: a position paper of the American Council on Science and Health.

Brown KG, Ross GL; American Council on Science and Health..

Regul Toxicol Pharmacol. 2002 Oct;36(2):162-74.

PMID:
12460751
10.

Assessment of cancer risk and environmental levels of arsenic in New Hampshire.

Karagas MR, Stukel TA, Tosteson TD.

Int J Hyg Environ Health. 2002 Mar;205(1-2):85-94.

PMID:
12018020
11.

Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.

Meliker JR, Slotnick MJ, AvRuskin GA, Schottenfeld D, Jacquez GM, Wilson ML, Goovaerts P, Franzblau A, Nriagu JO.

Cancer Causes Control. 2010 May;21(5):745-57. doi: 10.1007/s10552-010-9503-z. Epub 2010 Jan 19.

12.

A touch of poison.

Alpert M.

Sci Am. 2001 Jun;284(6):20-1. No abstract available.

PMID:
11396330
13.

Discontinuity in the cancer slope factor as it passes from high to low exposure levels--arsenic in the BFD-endemic area.

Lamm SH, Robbins S, Chen R, Lu J, Goodrich B, Feinleib M.

Toxicology. 2014 Dec 4;326:25-35. doi: 10.1016/j.tox.2014.08.014. Epub 2014 Sep 18.

PMID:
25241138
14.

Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.

Lamm SH, Robbins SA, Zhou C, Lu J, Chen R, Feinleib M.

Regul Toxicol Pharmacol. 2013 Feb;65(1):147-56. doi: 10.1016/j.yrtph.2012.10.012. Epub 2012 Nov 5.

15.
16.

Arsenic risk assessment.

Carlson-Lynch H, Beck BD, Boardman PD.

Environ Health Perspect. 1994 Apr;102(4):354-6.

17.

Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.

Tsuji JS, Alexander DD, Perez V, Mink PJ.

Toxicology. 2014 Mar 20;317:17-30. doi: 10.1016/j.tox.2014.01.004. Epub 2014 Jan 21. Review.

18.

Identifying US populations for the study of health effects related to drinking water arsenic.

Frost FJ, Muller T, Petersen HV, Thomson B, Tollestrup K.

J Expo Anal Environ Epidemiol. 2003 May;13(3):231-9.

19.

Arsenic exposure in US public and domestic drinking water supplies: a comparative risk assessment.

Kumar A, Adak P, Gurian PL, Lockwood JR.

J Expo Sci Environ Epidemiol. 2010 May;20(3):245-54. doi: 10.1038/jes.2009.24. Epub 2009 Apr 29.

PMID:
19401722
20.

Drinking water arsenic in northern chile: high cancer risks 40 years after exposure cessation.

Steinmaus CM, Ferreccio C, Romo JA, Yuan Y, Cortes S, Marshall G, Moore LE, Balmes JR, Liaw J, Golden T, Smith AH.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):623-30. doi: 10.1158/1055-9965.EPI-12-1190. Epub 2013 Jan 25.

Supplemental Content

Support Center